Alkermes
Alkermes
alkermes.com

Locations

Ireland · Dublin, Ireland · Wilmington, NC, USA · Waltham, MA, USA · Leinster, Ireland · Westmeath, Co. Westmeath, Ireland · Dun Laoghaire-Rathdown, Co. Dublin, Ireland

industry

Biotechnology

Size

1001 - 5000 employees

Stage

Other

founded in

1987

Alkermes, Inc. is an integrated biotechnology company. The company is engaged in the business of developing, manufacturing, and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures, and commercializes VIVITROL for alcohol dependence and manufactures RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system (CNS) disorders, reward disorders, addiction, diabetes, and autoimmune disorders. The company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.


Is this your company?

If you're responsible for hiring at this company, make sure your company and job information are always up to date to attract top talent from the Israel VC Forum network.

Something looks off?
Open jobs at Alkermes

On-site & Remote